The New York Times this week released a series of explosive articles detailing the tragic health risks experienced by those working in the nail salon industry.
from @ Health and Medical News http://ift.tt/1P9rUFV
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
